These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16392676)

  • 1. Fungal metabolites, sorbicillinoid polyketides and their effects on the activation of peroxisome proliferator-activated receptor gamma.
    Lee D; Lee JH; Cai XF; Shin JC; Lee K; Hong YS; Lee JJ
    J Antibiot (Tokyo); 2005 Oct; 58(10):615-20. PubMed ID: 16392676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells.
    Tjalkens RB; Liu X; Mohl B; Wright T; Moreno JA; Carbone DL; Safe S
    J Neurosci Res; 2008 Feb; 86(3):618-29. PubMed ID: 18041089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.
    Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S
    J Periodontal Res; 2007 Oct; 42(5):383-92. PubMed ID: 17760815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogues of 2-phenyl-ethenesulfonic acid phenyl ester have dual functions of inhibiting expression of inducible nitric oxide synthase and activating peroxisome proliferator-activated receptor gamma.
    Lee YZ; Yang CW; Kang IJ; Wu SH; Chao YS; Chern JH; Lee SJ
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5676-9. PubMed ID: 18809325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
    Han S; Roman J
    Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
    Fogo AB
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
    Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
    Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
    Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
    Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma.
    Siddiqui AM; Cui X; Wu R; Dong W; Zhou M; Hu M; Simms HH; Wang P
    Crit Care Med; 2006 Jul; 34(7):1874-82. PubMed ID: 16715036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
    Zheng S; Chen A
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G113-23. PubMed ID: 16959952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
    Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
    Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
    Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
    Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) gamma by organotin compounds.
    Hiromori Y; Nishikawa J; Yoshida I; Nagase H; Nakanishi T
    Chem Biol Interact; 2009 Jul; 180(2):238-44. PubMed ID: 19497422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
    Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
    Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
    Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
    Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.